Cervical Cancer Education · Pap · HPV · Colposcopy · Biopsy · FIGO

Cervical Cancer Diagnosis & Staging

Cervical cancer diagnosis and staging help determine whether abnormal cervical cells are precancerous or invasive, identify the cervical cancer type, evaluate tumor size, check local spread, assess lymph nodes and organize care planning. Evaluation may include Pap testing, HPV testing, colposcopy, biopsy, pathology, imaging and FIGO stage classification.

Educational information only. This page does not provide diagnosis, screening instructions, treatment recommendations or medical advice.
Pap
HPV
Colposcopy
Biopsy
FIGO
Diagnosis Overview

How cervical cancer may be diagnosed

Cervical cancer evaluation often begins after an abnormal Pap test, positive high-risk HPV test, visible cervical lesion, abnormal bleeding, unusual discharge, pelvic pain or symptoms that need gynecologic evaluation.

01

Screening result or symptoms

Pap and HPV tests can detect abnormal cervical cell changes or high-risk HPV, but they do not confirm invasive cancer by themselves.

02

Colposcopy and biopsy

Colposcopy magnifies the cervix so suspicious areas can be examined and sampled. Diagnosis usually depends on tissue biopsy and pathology.

03

Pathology and staging

Pathology confirms cancer type and invasion. Imaging and clinical assessment help define tumor extent, lymph nodes and FIGO stage.

Diagnosis Pathway

Common steps in cervical cancer evaluation

The diagnostic pathway depends on the screening result, symptoms, visible cervical findings, biopsy result and whether invasive cancer is suspected.

1
Pap test and HPV test

Pap testing looks for abnormal cervical cells. HPV testing checks for high-risk HPV types linked with cervical cancer risk.

2
Abnormal result review

Abnormal Pap or positive high-risk HPV results may lead to repeat testing, colposcopy or biopsy depending on risk level and clinical context.

3
Colposcopy

A colposcope magnifies the cervix, vagina and vulva so abnormal areas can be seen more clearly. Canadian Cancer Society notes colposcopy is often done after abnormal Pap or positive HPV testing.

4
Cervical biopsy

A small tissue sample is removed from suspicious areas and examined by a pathologist to check for precancer or cancer.

5
Endocervical sampling or cone biopsy

If needed, tissue from the cervical canal or a cone-shaped sample of cervix may be removed to clarify diagnosis or assess invasion.

6
Imaging and staging workup

Pelvic exam, MRI, CT, PET/CT, chest imaging or other tests may be used when invasive disease is confirmed or spread is suspected.

Diagnostic Map
Pap HPV Colposcopy Biopsy Pathology
Diagnostic Tests

Tests used in cervical cancer diagnosis

Cervical cancer diagnosis may include screening tests, visual examination, tissue sampling, pathology review and staging imaging. Pap and HPV tests are screening tests; biopsy confirms whether cancer is present.

Pap test

Collects cervical cells to look for abnormal changes, including precancerous or cancerous cell patterns.

HPV test

Detects high-risk HPV types associated with cervical precancer and cervical cancer risk.

Pelvic exam

Examines the cervix, vagina, uterus and surrounding pelvic structures for visible abnormalities or symptoms.

Colposcopy

Uses magnification and light to closely inspect the cervix and guide biopsy of abnormal areas.

Cervical biopsy

Removes a tissue sample so a pathologist can determine whether precancer or invasive cancer is present.

Cone biopsy / LEEP

Removes a cone-shaped piece of cervix using techniques such as LEEP, scalpel or laser to evaluate deeper tissue.

Pathology

Identifies squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, invasion depth, grade and margin status when reported.

Imaging

MRI, CT, PET/CT, ultrasound or chest imaging may help assess tumor extent, lymph nodes or distant spread.

Colposcopy
Acetic Acid Cervix Biopsy Pathology
Colposcopy & Biopsy

Why biopsy matters after abnormal screening

An abnormal Pap test or HPV test may suggest risk, but a biopsy is needed to confirm whether cells are precancerous or cancerous. Biopsy provides tissue architecture, invasion information and subtype clues that screening cannot provide.

Screening tests detect risk

Pap and HPV tests help identify abnormal cells or viral risk, but they do not confirm invasive cancer.

Colposcopy locates abnormal tissue

Magnified examination helps the clinician choose the most suspicious area to sample.

Biopsy confirms diagnosis

Pathology can distinguish inflammation, low-grade lesions, high-grade precancer and invasive cancer.

FIGO Staging

How cervical cancer staging works

Cervical cancer staging describes how far the cancer has grown or spread. The American Cancer Society states cervical cancer stages range from I to IV, where lower numbers mean less spread and stage IV means more advanced cancer. :contentReference[oaicite:1]{index=1}

I
Stage I

Cancer is found only in the cervix. NCI notes stage I is divided into IA and IB based on tumor size and depth of invasion. :contentReference[oaicite:2]{index=2}

II
Stage II

Cancer has grown beyond the cervix and uterus but has not reached the pelvic wall or the lower part of the vagina.

III
Stage III

Cancer may involve the lower vagina, pelvic wall, kidney drainage blockage or pelvic/para-aortic lymph nodes.

IV
Stage IV

Cancer has spread to nearby organs such as bladder or rectum, or to distant body sites.

FIGO Stage
Tumor Vagina Pelvis Nodes Distant
Stage Concepts

What doctors look for when staging cervical cancer

Staging combines clinical examination, pathology and imaging information to define tumor size, local spread, lymph-node involvement and distant metastasis.

Tumor size

Tumor measurement and depth of invasion help separate early microscopic disease from larger visible tumors.

Local extension

Evaluation checks whether disease extends beyond the cervix to the vagina, parametrium, pelvic wall or nearby organs.

Lymph nodes

Pelvic and para-aortic lymph-node involvement can change stage and treatment planning.

Distant spread

Imaging may check whether disease has spread beyond the pelvis to distant organs.

Pathology

What a cervical cancer pathology report can show

Pathology helps confirm diagnosis, cancer type, invasion pattern and details that may influence staging and treatment discussions.

Cancer type

Squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma or rare cervical tumor type.

Precancer grade

CIN, LSIL, HSIL or glandular abnormalities may be reported before invasive cancer.

Invasion depth

Depth of stromal invasion helps distinguish preinvasive disease from invasive cancer and early-stage categories.

Margins

For excisional procedures, margin status shows whether abnormal cells are present at the tissue edge.

Lymphovascular invasion

LVSI describes cancer cells in lymphatic or blood vessels and may influence risk assessment.

Biomarkers

Reports may include p16, HPV association, Ki-67, PD-L1 or other markers depending on clinical context.

Question Builder

Questions to ask after abnormal results

Select a topic to reveal practical questions for screening follow-up, biopsy, staging or pathology appointments.

Pap / HPV result questions

  • What exactly did my Pap or HPV result show?
  • Does this result suggest low-grade change, high-grade change or cancer concern?
  • Do I need repeat testing, colposcopy or biopsy?
  • How soon should follow-up happen?
Simple Summary

Cervical cancer diagnosis and staging in simple terms

Diagnosis confirms whether cervical cells are precancerous or cancerous. Staging explains how far invasive cervical cancer has spread.

How is cervical cancer usually evaluated?

Evaluation may include Pap testing, HPV testing, pelvic exam, colposcopy, cervical biopsy, cone biopsy or LEEP, pathology review and imaging if invasive cancer is confirmed.

What confirms cervical cancer?

A biopsy confirms cervical cancer by allowing a pathologist to examine cervical tissue under a microscope.

What does FIGO staging mean?

FIGO staging describes how far cervical cancer has grown or spread, from stage I limited to the cervix to stage IV spread to nearby organs or distant sites.

FAQ

FAQ: Cervical Cancer Diagnosis & Staging

Clear answers to common diagnosis and staging search questions.

How is cervical cancer diagnosed?

Cervical cancer is usually diagnosed through biopsy after abnormal screening, symptoms, visible cervical changes or colposcopy findings suggest cancer.

Can a Pap test diagnose cervical cancer?

No. A Pap test is a screening test. It can find abnormal cervical cells, but biopsy is needed to confirm cancer.

What is colposcopy?

Colposcopy is a magnified examination of the cervix, vagina and vulva used to look for abnormal areas and guide biopsy.

How is cervical cancer staged?

Cervical cancer is commonly staged with the FIGO system, which describes whether cancer is limited to the cervix or has spread to nearby tissues, lymph nodes or distant sites.

Is this page medical advice?

No. This page is educational only and does not replace consultation with a qualified healthcare professional.

References

Scientific References

Authoritative sources used to support this cervical cancer diagnosis and staging page.

  1. National Cancer Institute. Cervical cancer diagnosis and biopsy information.
  2. American Cancer Society. Tests for cervical cancer and cervical cancer staging.
  3. National Cancer Institute. Cervical cancer stages.
  4. Canadian Cancer Society. Cervical cancer diagnosis and colposcopy.
  5. Clinical literature on Pap/HPV screening follow-up, colposcopy, cervical biopsy, pathology and FIGO staging.